| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a112fa5dd8cc717ee8bdb5e4004d0b0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 |
| filingDate |
1998-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdd307a90af42760292def2f55862285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_076ded71733515deeddc1639bc0d8a36 |
| publicationDate |
2002-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1005349-A4 |
| titleOfInvention |
USE OF CYTIDINE AND CYTOSINE-CONTAINING COMPOUNDS FOR TREATING LIQUID USE |
| abstract |
Disclosed herein is a method for reducing stimulant dependencies in mammals that involves administration of a therapeutically-effective amount of a cytosine-containing or cytidine-containing compound, such as CDP-choline. |
| priorityDate |
1997-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |